Prion or PrPSc is the proteinaceous infectious agent causing prion diseases in various mammalian species. Despite decades of research, the structural basis for PrPSc formation and prion infectivity remains elusive. To understand the role of the hydrophobic region in forming infectious prion at the molecular level, we report X-ray crystal structures of mouse (Mo) prion protein (PrP) (residues 89-230) in complex with a nanobody (Nb484). Using the recombinant prion propagation system, we show that the binding of Nb484 to the hydrophobic region of MoPrP efficiently inhibits the propagation of proteinase K resistant PrPSc and prion infectivity. In addition, when added to cultured mouse brain slices in high concentrations, Nb484 exhibits no neuro...
Resistance to proteolytic digestion has long been considered a defining trait of prions in tissues o...
Prion diseases, also known as Transmissible Spongiform Encephalopathies, are neurodegenerative disea...
: Immunotherapy using antibodies to target the aggregation of flexible proteins holds promise for th...
Prion or PrPSc is the proteinaceous infectious agent causing prion diseases in various mammalian spe...
UNLABELLED: Prion diseases are a group of fatal and incurable neurodegenerative diseases affecting b...
Prions are fatal neurodegenerative transmissible agents causing several incurable illnesses in human...
Prions are fatal neurodegenerative transmissible agents causing several incurable illnesses in human...
Conversion of the cellular prion protein PrPC into its pathogenic isoform PrPSc is the hallmark of p...
Prions are lethal pathogens, which cause fatal neurodegenerative diseases in mammals. They are uniqu...
Resistance to proteolytic digestion has long been considered a defining trait of prions in tissues o...
Prion disorders are infectious diseases that are characterized by the conversion of the cellular pri...
Infectious prions cause diverse clinical signs and form an extraordinary range of structures, from a...
The infectious agent of transmissible spongiform encephalopathies (TSE) is believed to comprise, at ...
Prions are fatal neurodegenerative transmissible agents causing several incurable illnesses in human...
Mammalian prions are hypothesized to be fibrillar or amyloid forms of prion protein (PrP), but struc...
Resistance to proteolytic digestion has long been considered a defining trait of prions in tissues o...
Prion diseases, also known as Transmissible Spongiform Encephalopathies, are neurodegenerative disea...
: Immunotherapy using antibodies to target the aggregation of flexible proteins holds promise for th...
Prion or PrPSc is the proteinaceous infectious agent causing prion diseases in various mammalian spe...
UNLABELLED: Prion diseases are a group of fatal and incurable neurodegenerative diseases affecting b...
Prions are fatal neurodegenerative transmissible agents causing several incurable illnesses in human...
Prions are fatal neurodegenerative transmissible agents causing several incurable illnesses in human...
Conversion of the cellular prion protein PrPC into its pathogenic isoform PrPSc is the hallmark of p...
Prions are lethal pathogens, which cause fatal neurodegenerative diseases in mammals. They are uniqu...
Resistance to proteolytic digestion has long been considered a defining trait of prions in tissues o...
Prion disorders are infectious diseases that are characterized by the conversion of the cellular pri...
Infectious prions cause diverse clinical signs and form an extraordinary range of structures, from a...
The infectious agent of transmissible spongiform encephalopathies (TSE) is believed to comprise, at ...
Prions are fatal neurodegenerative transmissible agents causing several incurable illnesses in human...
Mammalian prions are hypothesized to be fibrillar or amyloid forms of prion protein (PrP), but struc...
Resistance to proteolytic digestion has long been considered a defining trait of prions in tissues o...
Prion diseases, also known as Transmissible Spongiform Encephalopathies, are neurodegenerative disea...
: Immunotherapy using antibodies to target the aggregation of flexible proteins holds promise for th...